The year is 2105. Technology has advanced dramatically, shaping a world where humanitystruggles. DGXXI, a avant-garde corporation, stands at the forefront of this transformation, pushing the boundaries of innovation. Its ambitious initiative - Echoes of Tomorrow - aims to influence the future by harnessing the power of biotechnology. The consequenc